Lactose Intolerance at IBS

Launched by ASSIUT UNIVERSITY · Apr 9, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "Lactose Intolerance at IBS," is studying how common lactose intolerance is in patients who experience chronic diarrhea, particularly those with a specific type of irritable bowel syndrome (IBS). The researchers want to find out if age and gender affect the likelihood of having lactose intolerance and to understand the symptoms that these patients experience. To participate, individuals must be over 18 years old, both men and women, and have been diagnosed with IBS that causes diarrhea. They will need to meet certain criteria related to their bowel movements and abdominal pain.

During the study, participants will fill out a questionnaire about their symptoms and undergo a test to determine if they have lactose intolerance using a method called PCR. This study is not yet recruiting participants, but if you or someone you know is dealing with IBS and chronic diarrhea, it may be an opportunity to contribute to important research and gain more insight into your condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * All Patients with IBS diarrhea dominant type meet Rome criteria attending at Al-Rajhy University Hospital during 6 months (from march to September). A patient must have recurrent abdominal pain (at least 1 day per week in the last 3 months) associated with at least two of the following:
• • 1. Related to defecation (pain improves or worsens with bowel movements).
• • 2. Change in stool frequency (diarrhea or constipation).
• • 3. Change in stool form (appearance) (loose, watery, hard, or lumpy).
• • Patients aged \>18 years.
• • Both males and females
• Exclusion Criteria:
• • -patient aged\<18 years old.
• • Patients with chronic diarrhea don't meet Rome criteria
• • patients with malignancies